F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC – Get Free Report) was the recipient of a large decline in short interest in April. As of April 30th, there was short interest totaling 2,968 shares, a decline of 50.9% from the April 15th total of 6,046 shares. Approximately 0.1% of the shares of the company are sold short. Based on an average trading volume of 3,055 shares, the short-interest ratio is currently 1.0 days.
F/m Emerald Life Sciences Innovation ETF Stock Down 3.3%
F/m Emerald Life Sciences Innovation ETF stock traded down $1.27 during mid-day trading on Friday, hitting $37.11. 962 shares of the company’s stock traded hands, compared to its average volume of 4,824. The firm has a 50 day moving average price of $36.06 and a 200 day moving average price of $36.09. F/m Emerald Life Sciences Innovation ETF has a one year low of $22.53 and a one year high of $40.10.
Institutional Trading of F/m Emerald Life Sciences Innovation ETF
An institutional investor recently raised its position in F/m Emerald Life Sciences Innovation ETF stock. Hunter Associates Investment Management LLC lifted its position in F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC – Free Report) by 13.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 45,908 shares of the company’s stock after buying an additional 5,312 shares during the period. Hunter Associates Investment Management LLC owned approximately 1.81% of F/m Emerald Life Sciences Innovation ETF worth $1,684,000 at the end of the most recent reporting period.
F/m Emerald Life Sciences Innovation ETF Company Profile
The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.
Read More
- Five stocks we like better than F/m Emerald Life Sciences Innovation ETF
- Robinhood, SoFi, and Webull Are Telling Very Different Stories
- As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In
- Target the Red-Hot Spin-Off and Merger Space With These ETFs
- Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes
Receive News & Ratings for F/m Emerald Life Sciences Innovation ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for F/m Emerald Life Sciences Innovation ETF and related companies with MarketBeat.com's FREE daily email newsletter.
